+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Duchenne Muscular Dystrophy Treatment Market

  • PDF Icon

    Report

  • 200 Pages
  • May 2024
  • Region: Global
  • Erevna Healthcare
  • ID: 5968446
The global Duchenne muscular dystrophy treatment market accounted for USD 3.19 billion in 2023 and is expected to reach USD 11.47 billion by 2034 with a CAGR of 12.34% during the forecast period 2024-2034. The market will grow due to the increasing prevalence of DMD, the growing demand for novel therapies, increased research and development (R&D) activities, the increased awareness of DMD and treatment options, and the growing focus on orphan drugs.

Pharmaceutical companies and academic organizations are investing significantly in discovering new, more effective DMD treatments. This corresponds to a strong pipeline of possible medicines, which keeps the market vibrant and forward-looking. Successful clinical trials and regulatory approvals for these innovative treatments will bolster market expansion. For instance, Sarepta Therapeutics reported favorable results from their Phase 3 ESSENCE trial, which evaluated SRP-5051, an experimental exon-skipping treatment for DMD.

By treatment, the steroid therapy segment accounted for the highest revenue-grossing segment in the global Duchenne muscular dystrophy treatment market in 2023 owing to the extensive clinical experience, established efficacy, and widespread adoption as a standard of care for managing symptoms and delaying disease progression in DMD patients. For instance, in December 2023, PTC Therapeutics announced the start of a Phase 1/2 clinical trial for PTC966, a possible therapy for DMD. Additionally, the molecular therapies segment is predicted to grow at the fastest CAGR during the forecast period owing to the rapid advancements in gene editing technologies, promising results from clinical trials, and the potential for personalized treatments targeting the underlying genetic cause of DMD.

By distribution channel, the hospital pharmacies segment accounted for the highest revenue-grossing segment in the global Duchenne muscular dystrophy treatment market in 2023 owing to the increased availability of specialty medications, including steroids and emerging therapies, and the convenience of accessing comprehensive care and specialized medications within hospital settings. For instance, in November 2023, Pfizer Inc. reported promising top-line findings from its Phase 3 STRIVE-EU trial of golodirsen for the treatment of DMD. Additionally, the retail pharmacies segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for convenience, expanding distribution networks, and increased accessibility of DMD treatments for patients in community settings.

North American region is anticipated to have the highest revenue share during the forecast period owing to the presence of well-established healthcare infrastructure, strong regulatory support for orphan drug development, and a higher prevalence of DMD cases compared to other regions. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to increasing awareness, improving healthcare infrastructure, and rising investments in rare disease research and development initiatives. For instance, in January 2023, Solid Biosciences announced the start of a Phase 1/2 clinical trial for SGT-001, an experimental microdystrophin gene therapy for DMD.

This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.

Report Scope:

  • Base Year: 2023
  • Forecast Period: 2024-2034
  • Study Coverage
  • Market Forecast by Treatment, and Distribution Channel
  • Market Forecast for 5 Regions and 17+ Countries
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
  • Exhaustive Company Profiles of the Top 10+ Major Market Players

Segmentation: Duchenne Muscular Dystrophy Treatment Market Report 2023 - 2034

Duchenne Muscular Dystrophy Treatment Market Analysis & Forecast by Treatment 2023 - 2034 (Revenue USD Bn)

  • Molecular Therapies
  • Steroid Therapy
  • Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Others

Duchenne Muscular Dystrophy Treatment Market Analysis & Forecast by Distribution Channel 2023 - 2034 (Revenue USD Bn)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Duchenne Muscular Dystrophy Treatment Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East & Africa
  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Duchenne Muscular Dystrophy Treatment Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Duchenne Muscular Dystrophy Treatment Market: Treatment Estimates & Trend Analysis
7.1. Treatment Segment Opportunity Analysis
7.2. Molecular Therapies
7.2.1. Molecular Therapies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Steroid Therapy
7.3.1. Steroid Therapy Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4. Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
7.4.1. Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.5. Others
7.5.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Duchenne Muscular Dystrophy Treatment Market: Distribution Channel Estimates & Trend Analysis
8.1. Distribution Channel Segment Opportunity Analysis
8.2. Hospital Pharmacies
8.2.1. Hospital Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Retail Pharmacies
8.3.1. Retail Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.4. Online Pharmacies
8.4.1. Online Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Regional Market Analysis
9.1. Regional Market Opportunity Analysis
10. North America Duchenne Muscular Dystrophy Treatment Market
10.1. North America Duchenne Muscular Dystrophy Treatment Market
10.1.1. North America Duchenne Muscular Dystrophy Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
10.1.2. North America Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
10.1.3. North America Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
10.1.4. North America Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
10.2. U.S. Global Duchenne Muscular Dystrophy Treatment Market
10.2.1. U.S. Duchenne Muscular Dystrophy Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
10.2.2. U.S. Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
10.2.3. U.S. Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
10.3. Canada Global Duchenne Muscular Dystrophy Treatment Market
10.3.1. Canada Duchenne Muscular Dystrophy Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
10.3.2. Canada Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
10.3.3. Canada Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11. Europe Global Duchenne Muscular Dystrophy Treatment Market
11.1. Europe Global Duchenne Muscular Dystrophy Treatment Market
11.1.1. Europe Duchenne Muscular Dystrophy Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.1.2. Europe Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
11.1.3. Europe Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
11.1.4. Europe Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11.2. Germany Global Duchenne Muscular Dystrophy Treatment Market
11.2.1. Germany Duchenne Muscular Dystrophy Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.2.2. Germany Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
11.2.3. Germany Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11.3. UK Global Duchenne Muscular Dystrophy Treatment Market
11.3.1. UK Duchenne Muscular Dystrophy Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.3.2. UK Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
11.3.3. UK Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11.4. France Global Duchenne Muscular Dystrophy Treatment Market
11.4.1. France Duchenne Muscular Dystrophy Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.4.2. France Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
11.4.3. France Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11.5. Spain Global Duchenne Muscular Dystrophy Treatment Market
11.5.1. Spain Duchenne Muscular Dystrophy Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.5.2. Spain Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
11.5.3. Spain Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11.6. Italy Global Duchenne Muscular Dystrophy Treatment Market
11.6.1. Italy Duchenne Muscular Dystrophy Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.6.2. Italy Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
11.6.3. Italy Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11.7. Rest of Europe Global Duchenne Muscular Dystrophy Treatment Market
11.7.1. Rest of Europe Duchenne Muscular Dystrophy Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.7.2. Rest of Europe Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
11.7.3. Rest of Europe Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12. Asia Pacific Global Duchenne Muscular Dystrophy Treatment Market
12.1. Asia Pacific Global Duchenne Muscular Dystrophy Treatment Market
12.1.1. Asia Pacific Duchenne Muscular Dystrophy Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. Asia Pacific Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. Asia Pacific Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.1.4. Asia Pacific Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.2. Japan Global Duchenne Muscular Dystrophy Treatment Market
12.2.1. Japan Duchenne Muscular Dystrophy Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. Japan Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.2.3. Japan Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.3. China Global Duchenne Muscular Dystrophy Treatment Market
12.3.1. China Duchenne Muscular Dystrophy Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. China Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.3.3. China Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.4. India Global Duchenne Muscular Dystrophy Treatment Market
12.4.1. India Duchenne Muscular Dystrophy Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.4.2. India Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.4.3. India Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.5. South Korea Global Duchenne Muscular Dystrophy Treatment Market
12.5.1. South Korea Duchenne Muscular Dystrophy Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.5.2. South Korea Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.5.3. South Korea Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.6. Australia Global Duchenne Muscular Dystrophy Treatment Market
12.6.1. Australia Duchenne Muscular Dystrophy Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.6.2. Australia Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.6.3. Australia Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.7. Rest of Asia Pacific Global Duchenne Muscular Dystrophy Treatment Market
12.7.1. Rest of Asia Pacific Duchenne Muscular Dystrophy Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.7.2. Rest of Asia Pacific Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
12.7.3. Rest of Asia Pacific Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13. Latin America Global Duchenne Muscular Dystrophy Treatment Market
13.1. Latin America Global Duchenne Muscular Dystrophy Treatment Market
13.1.1. Latin America Duchenne Muscular Dystrophy Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Latin America Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Latin America Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.1.4. Latin America Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.2. Brazil Global Duchenne Muscular Dystrophy Treatment Market
13.2.1. Brazil Duchenne Muscular Dystrophy Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Brazil Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.2.3. Brazil Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.3. Mexico Global Duchenne Muscular Dystrophy Treatment Market
13.3.1. Mexico Duchenne Muscular Dystrophy Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. Mexico Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.3.3. Mexico Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.4. Argentina Global Duchenne Muscular Dystrophy Treatment Market
13.4.1. Argentina Duchenne Muscular Dystrophy Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. Argentina Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.4.3. Argentina Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.5. Rest of Latin America Global Duchenne Muscular Dystrophy Treatment Market
13.5.1. Rest of Latin America Duchenne Muscular Dystrophy Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. Rest of Latin America Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
13.5.3. Rest of Latin America Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14. MEA Global Duchenne Muscular Dystrophy Treatment Market
14.1. MEA Global Duchenne Muscular Dystrophy Treatment Market
14.1.1. MEA Duchenne Muscular Dystrophy Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. MEA Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. MEA Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
14.1.4. MEA Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.2. GCC Global Duchenne Muscular Dystrophy Treatment Market
14.2.1. GCC Duchenne Muscular Dystrophy Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. GCC Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
14.2.3. GCC Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.3. South Africa Global Duchenne Muscular Dystrophy Treatment Market
14.3.1. South Africa Duchenne Muscular Dystrophy Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. South Africa Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
14.3.3. South Africa Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.4. Rest of MEA Global Duchenne Muscular Dystrophy Treatment Market
14.4.1. Rest of MEA Duchenne Muscular Dystrophy Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. Rest of MEA Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Treatment, 2023-2034 (Revenue USD Bn)
14.4.3. Rest of MEA Duchenne Muscular Dystrophy Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15. Competitor Analysis
15.1. Company Market Share Analysis, 2023
15.2. Major Recent Developments
16. Company Profiles
16.1. Sarepta Therapeutics
16.2. PTC Therapeutics
16.3. Pfizer Inc.
16.4. Santhera Pharmaceuticals
16.5. Solid Biosciences
16.6. Wave Life Sciences
16.7. Catabasis Pharmaceuticals
16.8. Roche Holdings
16.9. FibroGen, Inc.
16.10. Capricor Therapeutics
16.11. ReveraGen BioPharma
16.12. NS Pharma (a subsidiary of Nippon Shinyaku)
16.13. Italfarmaco Group
16.14. Nippon Shinyaku Co., Ltd.
16.15. Summit Therapeutics PLC
17. Conclusion18. Recommendations

Companies Mentioned

  • Sarepta Therapeutics
  • PTC Therapeutics
  • Pfizer Inc.
  • Santhera Pharmaceuticals
  • Solid Biosciences
  • Wave Life Sciences
  • Catabasis Pharmaceuticals
  • Roche Holdings
  • FibroGen Inc.
  • Capricor Therapeutics
  • ReveraGen BioPharma
  • NS Pharma (a subsidiary of Nippon Shinyaku)
  • Italfarmaco Group
  • Nippon Shinyaku Co. Ltd.
  • Summit Therapeutics PLC.